Published in J Med Genet on May 13, 2005
Alpha-thalassaemia. Orphanet J Rare Dis (2010) 2.40
HBB loss of heterozygosity in the hemopoietic lineage gives rise to an unusual sickle-cell trait phenotype. Haematologica (2012) 1.26
The prevention of thalassemia. Cold Spring Harb Perspect Med (2013) 1.25
Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia. Haematologica (2009) 1.00
Refinement of the genetic cause of ATR-16. Hum Genet (2007) 0.97
Rapid screening for chromosomal aneuploidies using array-MLPA. BMC Med Genet (2011) 0.91
Development and clinical implementation of a combination deletion PCR and multiplex ligation-dependent probe amplification assay for detecting deletions involving the human α-globin gene cluster. J Mol Diagn (2011) 0.89
Two new beta-thalassemia deletions compromising prenatal diagnosis in an Italian and a Turkish couple seeking prevention. Haematologica (2009) 0.87
Rapid screening of innate immune gene expression in zebrafish using reverse transcription - multiplex ligation-dependent probe amplification. BMC Res Notes (2011) 0.86
α-Thalassemia, mental retardation, and myelodysplastic syndrome. Cold Spring Harb Perspect Med (2012) 0.83
Rapid high-throughput analysis of DNaseI hypersensitive sites using a modified Multiplex Ligation-dependent Probe Amplification approach. BMC Genomics (2009) 0.83
Mosaic segmental uniparental isodisomy and progressive clonal selection: a common mechanism of late onset β-thalassemia major. Haematologica (2012) 0.80
Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach. BMC Genomics (2014) 0.80
Detection of exon skipping events in BRCA1 RNA using MLPA kit P002. Mol Biol Rep (2012) 0.79
Severe intrauterine anemia: a new form of epsilongammagammadeltabeta thalassemia presenting in utero in a Norwegian family. Haematologica (2009) 0.77
Comparison of the mismatch-specific endonuclease method and denaturing high-performance liquid chromatography for the identification of HBB gene mutations. BMC Biotechnol (2008) 0.76
Does absolute excess of alpha chains compromise the benefit of splenectomy in patients with thalassemia intermedia? Haematologica (2011) 0.76
A multiplex approach to the molecular diagnosis of β-thalassemia. J Mol Diagn (2011) 0.75
Characterization of Deletions of the HBA and HBB Loci by Array Comparative Genomic Hybridization. J Mol Diagn (2015) 0.75
Revisiting a Complex Rearrangement Involving a 619 Base Pairs Deletion, 6 Nucleotide Insertion Followed by a A > G Substitution Causing β°-Thalassemia. Indian J Hematol Blood Transfus (2016) 0.75
A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency. Hematol Rep (2011) 0.75
Rapid detection of pathological mutations and deletions of the haemoglobin beta gene (HBB) by High Resolution Melting (HRM) analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR). BMC Med Genet (2016) 0.75
A novel deletion of β-globin promoter causing high HbA2 in an Indian population. Haematologica (2012) 0.75
A combination of the -α(3.7) and --(MEDII) alleles causing hemoglobin H disease in a Brazilian patient. Rev Bras Hematol Hemoter (2016) 0.75
Detection of α-Thalassemia by Using Multiplex Ligation-Dependent Probe Amplification as an Additional Method for Rare Mutations in Southern Turkey. Indian J Hematol Blood Transfus (2015) 0.75
EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur J Hum Genet (2014) 0.75
BLAT--the BLAST-like alignment tool. Genome Res (2002) 126.78
Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood (2000) 3.36
Development and clinical application of an innovative fluorescence in situ hybridization technique which detects submicroscopic rearrangements involving telomeres. Eur J Hum Genet (1997) 2.59
MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat (2004) 2.03
Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol (2000) 1.95
Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. Proc Natl Acad Sci U S A (1979) 1.94
Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat (2004) 1.94
Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. I. Cases due to deletions involving chromosome band 16p13.3. Am J Hum Genet (1990) 1.87
BAC microarray analysis of 15q11-q13 rearrangements and the impact of segmental duplications. J Med Genet (2004) 1.87
Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat (2003) 1.57
Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood (1994) 1.55
Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet (2002) 1.55
Deletion of the mouse alpha-globin regulatory element (HS -26) has an unexpectedly mild phenotype. Blood (2002) 1.48
Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation-dependent probe amplification (MLPA). Hum Mutat (2004) 1.43
MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics (2005) 1.32
Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum Mol Genet (2001) 1.32
Molecular analysis of deletions in the human beta-globin gene cluster: deletion junctions and locations of breakpoints. Genomics (1990) 1.29
Understanding alpha globin gene expression: a step towards effective gene therapy. Semin Hematol (1998) 1.22
The involvement of Alu repeats in recombination events at the alpha-globin gene cluster: characterization of two alphazero-thalassaemia deletion breakpoints. Hum Genet (1997) 1.15
Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects. Eur J Hum Genet (2001) 1.12
Beta-thalassaemia. Baillieres Clin Haematol (1998) 1.02
Novel 112 kb (epsilonGgammaAgamma) deltabeta-thalassaemia deletion in a Dutch family. Br J Haematol (2003) 0.96
The molecular spectrum of beta-thalassemia and abnormal hemoglobins in the allochthonous and autochthonous dutch population. Community Genet (1998) 0.91
The 12.6 kilobase DNA deletion in Dutch beta zero-thalassaemia. Br J Haematol (1987) 0.89
Alpha-thalassaemia. Baillieres Clin Haematol (1998) 0.89
Genetic polymorphism of the major regulatory element HS-40 upstream of the human alpha-globin gene cluster. Br J Haematol (2002) 0.83
The DNA deletion in an Indian delta beta-thalassaemia begins one kilobase from the A gamma globin gene and ends in an L1 repetitive sequence. Br J Haematol (1989) 0.83
A novel 7.9 kb deletion causing alpha+-thalassaemia in two independent families of Indian origin. Br J Haematol (2003) 0.81
Rapid detection of a 13.4-kb deletion causing delta beta thalassemia in an Egyptian family by polymerase chain reaction. Blood (1993) 0.80
A de novo deletion causing epsilon gamma delta beta-thalassemia in a Dutch patient. Acta Haematol (1996) 0.80
alpha-Thalassemia in The Netherlands: a heterogeneous spectrum of both deletions and point mutations. Hum Genet (1997) 0.80
Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions. Clin Lab Haematol (1990) 0.79
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics (1988) 3.18
WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet (1998) 2.77
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord (2011) 2.47
Statistical errors in papers in the British Journal of Psychiatry. Br J Psychiatry (1979) 2.38
The relationship context of contraceptive use at first intercourse. Fam Plann Perspect (2000) 2.24
The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett (2000) 2.24
ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol (2011) 2.23
[The 'Anemia in the midwife practice' standard issued by the Royal Dutch Organisation of Midwives: a risk of not recognizing iron deficiency and hemoglobinopathy]. Ned Tijdschr Geneeskd (2002) 2.13
Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet (1993) 2.08
Inadvertent esophageal intubation in the field: reliance on a fool's "gold standard". Acad Emerg Med (1997) 2.07
Relationship between neonatal screening results by HPLC and the number of α-thalassaemia gene mutations; consequences for the cut-off value. J Med Screen (2011) 2.05
Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89
Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest (2007) 1.85
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet (2001) 1.76
Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet (1996) 1.67
Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients. Blood Cells Mol Dis (2008) 1.63
Duplications in the DMD gene. Hum Mutat (2006) 1.58
Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A (2005) 1.54
In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin. Antimicrob Agents Chemother (1984) 1.50
Recommendations for locus-specific databases and their curation. Hum Mutat (2008) 1.49
MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. AJNR Am J Neuroradiol (1992) 1.49
The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal. Br J Obstet Gynaecol (1997) 1.44
[Acute anaemia in a Vietnamese patient with alpha-thalassaemia and a parvovirus infection]. Ned Tijdschr Geneeskd (2006) 1.40
The need for evaluation of gastroesophageal reflux in brain-damaged children referred for feeding gastrostomy. J Pediatr Surg (1981) 1.39
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A (1997) 1.36
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells. Gene Ther (2004) 1.31
Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J (2005) 1.31
Promoters and control elements: designing expression cassettes for gene therapy. Curr Gene Ther (2004) 1.30
Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res (2006) 1.29
Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy. Lancet (1979) 1.27
Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol (2009) 1.27
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics (2005) 1.23
Strict co-linearity of genetic and protein folding domains in an intragenically duplicated rat lens gamma-crystallin gene. J Mol Biol (1983) 1.21
Relative power and sample size analysis on gene expression profiling data. BMC Genomics (2009) 1.21
Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk. Am J Hum Genet (1992) 1.21
Structural variation in mammalian gamma-crystallins based on computer graphics analyses of human, rat and calf sequences. 1. Core packing and surface properties. Exp Eye Res (1986) 1.20
Copy number variation and mosaicism. Cytogenet Genome Res (2009) 1.20
Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients. Neuromuscul Disord (2010) 1.19
Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet (2009) 1.17
Characterization of mouse A33 antigen, a definitive marker for basolateral surfaces of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2000) 1.17
Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. J Pathol (2007) 1.17
The involvement of Alu repeats in recombination events at the alpha-globin gene cluster: characterization of two alphazero-thalassaemia deletion breakpoints. Hum Genet (1997) 1.15
High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization. Nucleic Acids Res (1989) 1.15
Concerted and divergent evolution within the rat gamma-crystallin gene family. J Mol Biol (1986) 1.13
Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia. Br J Haematol (1990) 1.13
An automatic registration method for frameless stereotaxy, image guided surgery, and enhanced reality visualization. IEEE Trans Med Imaging (1996) 1.11
Characterization of SCML1, a new gene in Xp22, with homology to developmental polycomb genes. Genomics (1998) 1.11
Predictive diagnosis of myotonic dystrophy with flanking microsatellite markers. J Med Genet (1991) 1.10
Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. Am J Hum Genet (1996) 1.10
CTX, a Xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates. Eur J Immunol (1998) 1.10
Variation of CNV distribution in five different ethnic populations. Cytogenet Genome Res (2007) 1.10
Imaging ROMK1 inwardly rectifying ATP-sensitive K+ channel protein using atomic force microscopy. Proc Natl Acad Sci U S A (1996) 1.09
Non-Hodgkin lymphoma of bone. Radiology (1980) 1.09
Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Br J Radiol (2002) 1.09
Stimulation of fibroblast proliferation and prostaglandin production by purified recombinant murine interleukin 1. Clin Immunol Immunopathol (1986) 1.09
Protein truncation test (PTT) to rapidly screen the DMD gene for translation terminating mutations. Neuromuscul Disord (1994) 1.08
Prevalence and molecular heterogeneity of alfa+ thalassemia in two tribal populations from Andhra Pradesh, India. Hum Genet (1988) 1.06
Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family. Eur J Hum Genet (2000) 1.06
Pneumatosis intestinalis in dermatomyositis. Br J Radiol (1980) 1.04
Patterns of calcification in childhood dermatomyositis. AJR Am J Roentgenol (1984) 1.04
Identification of SCML2, a second human gene homologous to the Drosophila sex comb on midleg (Scm): A new gene cluster on Xp22. Genomics (1999) 1.04
Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann Rheum Dis (2008) 1.04
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm (Vienna) (2001) 1.03
Application of in vitro Myo-differentiation of non-muscle cells to enhance gene expression and facilitate analysis of muscle proteins. Neuromuscul Disord (1996) 1.03
Purification and primary structure of ceratotoxin A and B, two antibacterial peptides from the female reproductive accessory glands of the medfly Ceratitis capitata (Insecta:Diptera). Insect Biochem Mol Biol (1993) 1.03
Consensus sequences of the Rattus norvegicus B1- and B2 repeats. Nucleic Acids Res (1987) 1.02
The crystallin gene families. Ciba Found Symp (1984) 1.01
Skeletal abnormalities of acrogeria, a progeroid syndrome. Skeletal Radiol (1987) 1.00
Two human gamma-crystallin genes are linked and riddled with Alu-repeats. Gene (1985) 0.99
The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol (2009) 0.99
Genomic imbalances in mental retardation. J Med Genet (2004) 0.97
Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame. J Med Genet (1992) 0.96
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet (1993) 0.96
High-resolution DNA Fiber-FISH for genomic DNA mapping and colour bar-coding of large genes. Hum Mol Genet (1995) 0.96
The human genome project and the future of diagnostics, treatment, and prevention. Lancet (1999) 0.95
Accuracy and time requirements of a bar-code inventory system for controlled substances. Am J Hosp Pharm (1989) 0.95
Adult, fetal, and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product. Lab Invest (1996) 0.95
Medication errors reduced by unit-dose. Hospitals (1973) 0.95
Methods to detect CNVs in the human genome. Cytogenet Genome Res (2009) 0.94
Molecular spectrum of beta-thalassemia in the Iranian Province of Hormozgan. Hemoglobin (2001) 0.94
Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I. Am J Hum Genet (1992) 0.94
Construction and screening of Mycobacterium paratuberculosis insertional mutant libraries. Arch Microbiol (2000) 0.93
After the introduction into the national newborn screening program: who is receiving genetic counseling for hemoglobinopathies in the Netherlands? Public Health Genomics (2013) 0.93
Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene. Differentiation (1992) 0.93
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium. J Biol Chem (1996) 0.93
Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation (2000) 0.93
The gamma-crystallin gene families: sequence and evolutionary patterns. J Mol Evol (1988) 0.92
Extensive intragenic sequence homology in two distinct rat lens gamma-crystallin cDNAs suggests duplications of a primordial gene. Proc Natl Acad Sci U S A (1982) 0.92
Colonic strictures in children with cystic fibrosis. Radiology (1995) 0.92
Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient. Allergy (2009) 0.92
A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology (2001) 0.92
Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J Neuropathol Exp Neurol (1999) 0.91
Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example. Prenat Diagn (2009) 0.91
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients. J Med Genet (1993) 0.91
Gastrointestinal complications of gastroschisis. AJR Am J Roentgenol (1985) 0.91